Heinrich-Heine-University Reports Findings in Myasthenia Gravis (Inter-alpha-try psin inhibitor heavy chain H3 is a potential biomarker for disease activity in m yasthenia gravis)
Heinrich-Heine-University Reports Findings in Myasthenia Gravis (Inter-alpha-try psin inhibitor heavy chain H3 is a potential biomarker for disease activity in m yasthenia gravis)
扫码查看
点击上方二维码区域，可以放大扫码查看
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Autoimmune Diseases an d Conditions - Myasthenia Gravis is the subject of a report. According to news r eporting out of Dusseldorf, Germany, by NewsRx editors, research stated, “Myasth enia gravis is a chronic antibody-mediated autoimmune disease disrupting neuromu scular synaptic transmission. Informative biomarkers remain an unmet need to str atify patients with active disease requiring intensified monitoring and therapy; their identification is the primary objective of this study.”
Key words
Dusseldorf/Germany/Europe/Autoimmune Diseases and Conditions of the Nervous System/Biomarkers/Cyborgs/Diagnostics and Screening/Drugs and Therapies/Emerging Technologies/Enzyme Inhibitors/En zymes and Coenzymes/Health and Medicine/Machine Learning/Myasthenia/Myasthen ia Gravis/Neurology/Peptide Hydrolases/Serine Endopeptidases/Serine Proteina se Inhibitors/Trypsin/Trypsin Inhibitors
NETL
NSTL